Aytu BioPharma, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
10.9M
on 2026-09-15, from 5.57M on 2024-03-31 10-K ↗
a raise that quarter, at its price
Newest
S-3 of 2024-09-26. Not read yet. S-3 ↗
2 of its filings are not read yet.
Cash
$26.3M
Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-K ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-06-05 | Public offering | not read | $1.50 | $14.4M | 424B4 ↗ |